OneWater Marine, Inc. (ONEW)
NASDAQConsumer DiscretionarySpecialty RetailSnapshot 2026-09-04
$12.70+7.35%
Close 2026-09-04 · 1-day change
NASDAQConsumer DiscretionarySpecialty RetailSnapshot 2026-09-04
Broken: Primary pillar broken — Revenue near $1.83 billion next quarter: rev $1.75B-$1.80B vs $1.78B.
OneWater aims for adjusted EBITDA between $60M and $80M in 2026. Revenue is expected near $1.83 billion next quarter. The company completed a key acquisition to grow. Earnings estimates are improving slightly.
OneWater is still loss-making and missed earnings several times recently. Revenue growth is weak at about 2%. The sector faces headwinds that could hurt sales. Profit margins may stay thin.
The price is about 11% above our fair value near $10. Analysts expect 2% revenue growth, which the market reflects. Our fair value is 27% below the Street median, so weigh the Street range carefully.
Breaks if: Acquisition fails to contribute positively by FY 2026
Finalize and integrate the acquisition of Ocean Bio-Chem to expand product offerings and market presence.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround opportunity with a focus on stabilizing operations. The current thesis is cautious due to recent earnings misses and mixed management performance.
The market appears to have priced in a cheap valuation compared to peers, with an expectations gap indicating lower anticipated performance. The current valuation suggests that investors are not overly optimistic about future growth.
Management is on track to achieve adjusted EBITDA targets, but same-store sales have shown declines, indicating challenges. The near-term risk of an earnings miss is elevated, which could impact future performance.
The thesis hinges on management's ability to stabilize same-store sales and the broader Consumer Discretionary sector performance. Key triggers include guidance changes and inflation trends that could affect market sentiment.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. This change is driven by the latest earnings miss. The company reported a non-GAAP EPS of 0.73, which was below consensus expectations. This performance indicates ongoing challenges in meeting market forecasts.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 2 of last 3 quarters. The acquisition was completed by 2026-Q1, with subsequent divestiture impacts noted in 2026-Q2 and Q3 revenues. Management has executed the acquisition, indicating delivery on this priority.
“The sale of Ocean Bio-Chem Holdings, Inc. ("OBCI") divestiture impacted revenue.”
“Purchase Agreement governs the sale of Ocean Bio-Chem; acquisition completed.”
Breaks if: Adjusted EBITDA falls below $60M in FY 2026
Breaks if: Revenue falls below $1.78B next quarter
Breaks if: Same-store sales decline year over year in FY 2026
Manage operations to keep dealership same-store sales flat year over year despite industry challenges.
Stated as a priority in 3 of last 3 quarters. Same-store sales declined 2% in 2026-Q3 and 8% in 2026-Q2, despite management's expectation of flat sales for fiscal 2026. The trajectory shows mixed results with recent declines, indicating challenges in maintaining flat sales.
“Same-store sales decreased 2%.”
“Same-store sales decreased 8%.”
“Company expects dealership same-store sales to be flat year over year.”
Overall, ONEW's long-term outlook is uncertain, with mixed performance and elevated risks. Not investment advice.